Rey, an Austin, Texas-based psychological well being and wellness startup integrating immersive instruments and digital interventions with teletherapy, introduced the debut of its digital psychological wellness platform.
The platform, which is powered by OxfordVR, a spin-out of Oxford College, will initially be accessible throughout Texas with a highway map to achieve the remainder of the U.S. in 2022. The preliminary pricing begins at $36 per session and a month-to-month subscription value of $295, though the corporate additionally famous it will offer customers a 50 p.c low cost for the primary month with the platform.
The service combines individualized care with VR instruments to raise therapy progress to retrain the mind. It presents custom-made remedy periods designed to set off the identical psychological and physiological reactions as real-life conditions. The purpose is to get what sufferers be taught from VR to stick with them in the true world.
Rey, which launched in April 2021, makes use of a customized mixture of cognitive behavioral remedy, speak remedy, remedy capabilities, and clinically validated tech instruments resembling digital actuality (VR).
The corporate makes a speciality of collaborative care with a full-time workers of multidisciplinary specialists, together with specialists throughout CBT, EMDR, meditation, mindfulness and life teaching.
The corporate was based by Deepak Gopalakrishna, a geneticist who moved into the enterprise facet and has launched different biotech startups. In July, the corporate introduced that it has raised $10 million in new funding, bringing its whole Sequence A funding spherical to $26 million.
OxfordVR, was based is targeted on using VR in extreme psychological sickness. The corporate founder Dr. Daniel Freeman, professor of scientific psychology at Oxford College, is the senior scientific advisor to Rey for growth of recent automated therapeutics. Potential future remedies embrace obsessive-compulsive dysfunction and substance use dysfunction.
The variety of sufferers with melancholy and nervousness has surged as psychologists responded to the Coronavirus pandemic, in keeping with a November 2020 survey by the American Psychological Affiliation.
The overwhelming majority (96%) of psychologists stated they have been treating sufferers remotely–64% have been treating all sufferers remotely – and 32% have been treating some sufferers in individual and a few remotely.
Nearly all of psychologists (63%) stated they discovered treating sufferers remotely tougher than treating sufferers in individual, with round 1 / 4 of survey respondents reporting “a good quantity of or extra” challenges or limitations for sufferers to obtain therapy by way of telehealth.